Geneva, April 21, 2022 -The World Health Organization said Friday it “strongly recommended” Pfizer’s Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at…
By Michael Erman – Pfizer Inc is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries this year, according…
MUMBAI: A total of 11 billion Covid-19 vaccine doses were produced and delivered to countries globally in 2021, which is twice the volume of the total global vaccine market in…
HOUSTON: Corbevax, a ‘recombinant protein sub-unit’ vaccine developed by Texas-based vaccine developers, was recently granted emergency approval by the Indian government and will be manufactured by the Hyderabad-based company Biological…
The U.S. recently added two new weapons to its small arsenal against the coronavirus: pills that patients can take at home to treat COVID-19. The drugs from Pfizer and Merck…
SYDNEY: Australia’s political leaders were set to hold an emergency meeting on Wednesday as cases of the Omicron coronavirus variant broke infection records and forced countries around to world to…
By Pushkala Aripaka and Francesco Guarascio The European Union on Monday approved the use of Novavax’s COVID-19 vaccine in people 18 years and older, giving a boost to the U.S.…
New Delhi : Reports released by dental organisations revealed that the number of people opting for tele-dentistry to seek dental advice has risen significantly in the post-pandemic world. The advent…
Washington: Pfizer said Tuesday that clinical trials confirmed its Covid pill — a new type of treatment that should withstand the mutations seen with the Omicron variant — drastically reduced…
CHAVANNES-DE-BOGIS: The head of vaccine alliance Gavi, which is leading a UN-backed push to get Covid-19 vaccines to developing countries, said that he’s seen early signs that rich countries are…
